Pancreatic mediastinal pseudocyst presenting as a posterior mediastinal mass with recurrent pleural effusions: a case report and review of the literature
© Karamouzos et al. 2015
Received: 4 November 2014
Accepted: 30 March 2015
Published: 12 May 2015
A rare complication of chronic pancreatitis is the formation of single or multiple mediastinal pseudocysts, which are fueled from the pancreas through anatomical openings of the diaphragm. We present a rare case with a difficult diagnosis, treatment and potentially catastrophic complications.
A 53-year-old Caucasian man was referred to our hospital for further investigation and treatment of a large heterogeneous mass situated in the posterior mediastinum, and bilateral pleural effusions which had developed after recent multiple episodes of pancreatitis. He had a history of chronic alcoholism. Laboratory and imaging modalities established the diagnosis of a pancreatic mediastinal pseudocyst.
Despite successful initial conservative treatment, our patient had a relapse and underwent emergency surgical intervention due to internal hemorrhage. We present his diagnostic and imaging workup, along with the multidisciplinary intervention, and a literature review referring to the diagnosis and treatment of mediastinal pancreatic pseudocysts.
KeywordsPancreatic pseudocysts Mediastinal pseudocysts Pancreatitis Alcohol abuse Recurrent pleuritis Posterior mediastinal mass
One of the most common complications of chronic pancreatitis is the development of pseudocysts due to stenosis or disruption of the pancreatic duct. These can be numerous and their size varies from a few centimeters to 30cm in some cases. They are rich in enzymes and are held together by fibrous and granulomatous tissue, hence the term pseudocyst. In some cases they can invade adjacent organs, such as the liver [1,2] and spleen , and sometimes may extend above the diaphragm.
We herein present a patient with a history of alcohol abuse who was referred to our hospital for further investigation and treatment of a mass in the posterior mediastinum, and bilateral pleural effusions, which had developed after recent multiple episodes of pancreatitis.
Peripheral blood laboratory results
Pleural fluid results
Two months after his discharge he was readmitted with clinical signs of respiratory distress and bilateral pleural effusion was visible on his radiology chest imaging. The results from his serum blood and pleural fluid laboratory tests were similar to his first admission. As similar findings were identified on his chest and abdomen CT scan compared to the images from his last admission, a decision for surgical intervention was made. Upon completion of the preoperative diagnostic workup he was transferred to the general surgery ward. He was on a triple antibiotic regimen (meropenem, vancomycin and fluconazole) and was scheduled for elective surgery. On the fourth hospitalization day he suffered from nausea, vomiting and abdominal pain. His physical exam showed that his abdomen was rigid, with noted pain on the upper abdomen and guarding. His laboratory tests showed a significant drop in his hemoglobin level and his vital signs revealed borderline tachycardia. After resuscitation with fluids and blood transfusions, a CT scan of his abdomen was performed where an extended hematoma at the lesser sac was identified with no active bleeding. Subsequently, he underwent an elective embolization of the splenic artery followed by an emergency laparotomy. Intraoperatively, a sizable hematoma was found at the lesser sac, pushing his stomach anteriorly. Due to chronic inflammation his pancreas was fibrous and hard. The splenic vein was thrombosed and splenomegaly with left-sided portal hypertension was present. A distal pancreatectomy with splenectomy was performed; his post-operative course was uneventful and he was discharged on the 11th postoperative day.
Tumors that are most commonly located in the posterior mediastinum are of esophageal and nervous origin. Hernias, aortic aneurysms and duplication cysts can also be found in this anatomic area. Some cases of extramedullary hematopoiesis  and pancreatic pseudocysts are also reported in the literature. After a rupture of the posterior pancreatic duct, the pancreatic fluid is usually confined in the retroperitoneal space, but can occasionally slip into the posterior mediastinum from the esophageal or the aortic hiatus, leading to the formation of pseudocysts. If the diaphragm is penetrated through the inferior vena cava hiatus or the foramen of Morgagni, the pseudocyst will be formed in the middle and anterior mediastinum, respectively . Published data report that these cysts can occur at any age from 7 months to 73 years, and the leading cause in adults is chronic alcoholic pancreatitis and trauma in children . The related symptoms may vary from chest pain, palpitations, dysphagia, pleural effusion with concomitant dyspnea, cough and hemoptysis, to severe life-threatening complications such as hemothorax, cardiac tamponade, esophagobronchial fistula and acute airway obstruction [7-10].
Computed tomography and magnetic resonance imaging are the most commonly used imaging modalities to reveal the size, location and possible communications of the pseudocysts with the pancreas. Furthermore, magnetic resonance computed pancreatography in conjunction with esophageal retrograde cholangiopancreatography can unveil strictures and disruption of the pancreatic duct. A transesophageal fine needle aspiration can be performed when a differential diagnosis problem is raised, but the patient’s medical history and CT imaging study are usually adequate for the diagnosis to be established.
The management of a mediastinal pancreatic pseudocyst is a difficult task. Relapses are common and procedural complications are many. At the moment there are no guidelines addressing this problem. A literature review revealed only a few scant reports of spontaneous resolution [11,12], but in the vast majority of cases intervention was mandatory, and the approach has to be individually tailored.
Conservative treatment with strict diet, enzyme supplementation and complete abstinence from alcohol is indicated to all stable patients. In addition, bromhexine hydrochloride and somatostatin analogues have been used in a few cases [13-15]. Somatostatin and its analog octreotide are peptide hormones that inhibit the release of insulin, glucagon, gastrin, secretin, pancreozymin and pepsin. In our patient, octreotide was successfully administered at a dose of 0.5mg (administered subcutaneously), three times daily, for one month following his first admission.
In certain cases, minimally invasive procedures can resolve the problem and help patients to avoid surgery. Patients with pancreatic duct disruption and stenosis can be treated with the placement of stents or with naso-pancreatic drainage, in order to restore the duct patency and seize the pseudocyst fuelling. For other patients with large abdominal pseudocysts that communicate with the mediastinum, CT-guided abdominal percutaneous drainage may be the optimal treatment [16-20]. In our patient, the magnetic resonance cholangiopancreatography showed no patency problems of the pancreatic duct, and the 2cm cyst beside the pancreatic tail was too small to be accessed and drained. To date, surgery with or without pancreatectomy is the most commonly used treatment, alongside internal drainage of the stomach, or percutaneous drainage when applicable.
Mediastinal pancreatic pseudocyst is a rare complication of alcohol related pancreatitis, with potentially catastrophic complications and a difficult treatment course. A multidisciplinary approach is mandatory for achieving an optimal outcome.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Baydar B, Cantürk F, Alper E, Aslan F, Akpınar Z, Cengız O, et al. Intrahepatic localization of pancreatic pseudocyst: a case report. Turk J Gastroenterol. 2013;24:447–9.View ArticlePubMedGoogle Scholar
- Shibasaki M, Bandai Y, Ukai T. Pancreatic pseudocyst extending into the liver via the hepatoduodenal ligament: a case report. Hepatogastroenterology. 2002;49:1719–21.PubMedGoogle Scholar
- Rana SS, Chaudhary V, Sharma V, Sharma R, Dutta U, Bhasin DK. Infected pancreatic pseudocyst of spleen successfully treated by combined endoscopic transpapillary stent placement and transmural aspiration. Gastrointest Endosc. 2014;79:360–1.View ArticlePubMedGoogle Scholar
- Yu YC, Kao EL, Chou SH, Lin TJ, Lin TJ, Chien CH. Intrathoracic extramedullary hematopoiesis simulating posterior mediastinal mass–report of a case in patient with beta-thalassemia intermedia. Gaoxiong Yi Xue Ke Xue Za Zhi. 1991;7:43–8.PubMedGoogle Scholar
- Xu H, Zhang X, Christe A, Ebner L, Zhang S, Luo Z, et al. Anatomic pathways of peripancreatic fluid draining to mediastinum in recurrent acute pancreatitis: visible human project and CT study. PLoS One. 2013;8, e62025.View ArticlePubMedPubMed CentralGoogle Scholar
- Johnston Jr RH, Owensby LC, Vargas GM, Garcia-Rinaldi R. Pancreatic pseudocyst of the mediastinum. Ann Thorac Surg. 1986;41:210–2.View ArticlePubMedGoogle Scholar
- Edwards RD, Jardine A, Vallance R. Case report: pancreatic mediastinal pseudocyst–an unusual cause of palpitations. Clin Radiol. 1992;45:128–30.View ArticlePubMedGoogle Scholar
- Olah A, Nagy AS, Racz I, Gamal ME. Cardiac tamponade as a complication of pseudocyst in chronic pancreatitis. Hepatogastroenterology. 2002;49:564–6.PubMedGoogle Scholar
- Tanaka A, Takeda R, Utsunomiya H, Kataoka M, Mukaihara S, Hayakawa K. Severe complications of mediastinal pancreatic pseudocyst: report of esophagobronchial fistula and hemothorax. J Hepatobiliary Pancreat Surg. 2000;7:86–91.View ArticlePubMedGoogle Scholar
- Bardia A, Stoikes N, Wilkinson NW. Mediastinal pancreatic pseudocyst with acute airway obstruction. J Gastrointest Surg. 2006;10:146–50.View ArticlePubMedGoogle Scholar
- Santoshkumar S, Seith A, Rastogi R, Khilnani GC. Mediastinal pseudocysts in chronic pancreatitis with spontaneous resolution. Trop Gastroenterol. 2007;28:32–4.PubMedGoogle Scholar
- Leechawengwong M, Berger HW, Romeu J. Spontaneous resolution of mediastinal pancreatic pseudocyst. Chest. 1979;75:632–3.View ArticlePubMedGoogle Scholar
- Tsujimoto T, Takano M, Tsuruzono T, Hoppo K, Matsumura Y, Yamao J, et al. Mediastinal pancreatic pseudocyst caused by obstruction of the pancreatic duct was eliminated by bromhexine hydrochloride. Intern Med. 2004;43:1034–8.View ArticlePubMedGoogle Scholar
- Suga H, Tsuruta O, Okabe Y, Saitoh F, Noda T, Yoshida H, et al. A case of mediastinal pancreatic pseudocyst successfully treated with somatostatin analogue. Kurume Med J. 2005;52:161–4.View ArticlePubMedGoogle Scholar
- Ishibashi K, Suzuki T, Isoo Y, Tsutsumi H, Tsutsumi H, Nagasawa M, et al. A case of mediastinal pancreatic pseudocysts successfully treated with somatostatin analogue. Nihon Shokakibyo Gakkai Zasshi. 1999;96:176–80.PubMedGoogle Scholar
- Kim D-J, Chung H-W, Gham C-W, Na H-G, Park S-W, Lee S-J, et al. A case of complete resolution of mediastinal pseudocyst and pleural effusion by endoscopic stenting of pancreatic duct. Yonsei Med J. 2003;44:727–31.View ArticlePubMedGoogle Scholar
- Bhasin DK, Rana SS, Nanda M, Chandail VS, Masoodi I, Kang M, et al. Endoscopic management of pancreatic pseudocysts at atypical locations. Surg Endosc. 2010;24:1085–91.View ArticlePubMedGoogle Scholar
- Bhasin DK, Rana SS, Chandail VS, Nanda M, Sinha SK, Nagi B. Successful resolution of a mediastinal pseudocyst and pancreatic pleural effusion by endoscopic nasopancreatic drainage. JOP. 2005;6:359–64.PubMedGoogle Scholar
- Faling LJ, Gerzof SG, Daly BD, Pugatch RD, Snider GL. Treatment of chronic pancreatitic pleural effusion by percutaneous catheter drainage of abdominal pseudocyst. Am J Med. 1984;76:329–33.View ArticlePubMedGoogle Scholar
- Mallavarapu R, Habib TH, Elton E, Goldberg MJ. Resolution of mediastinal pancreatic pseudocysts with transpapillary stent placement. Gastrointest Endosc. 2001;53:367–70.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.